Inflammation marker could help vets pinpoint the cause of respiratory distress in cats
Measuring serum amyloid A (SAA) could help clinicians tell inflammatory lower respiratory tract disease apart from heart failure and cancer in cats presenting with respiratory distress, according to new research published in the Journal of Small Animal Practice.
SAA is the major acute-phase protein in cats and is already used as a marker of inflammation. The team, based at a referral hospital in Lille, France, wanted to know whether it could also help with one of the trickier diagnostic questions in feline emergency medicine: why a cat is struggling to breathe.
The researchers reviewed the records of 22 cats admitted with respiratory distress between October 2021 and December 2024, all of which had SAA measured within 48 hours of arrival. Fifteen had inflammatory lower respiratory tract disease, a group that included aspiration pneumonia, feline lower airway disease and pulmonary toxoplasmosis. The remaining seven had cardiac or neoplastic disease: three had left-sided congestive heart failure, and four had either pulmonary adenocarcinoma or mediastinal lymphoma.
Clear gap between groups
SAA levels differed markedly. The inflammatory cats had a median of 57.5μg/mL, against 5μg/mL in the cardiac and neoplastic cats.
The authors proposed a cut-off of 8.6μg/mL to separate the two groups. At this threshold, sensitivity was 80 per cent and specificity was 100 per cent. When the cardiac and neoplastic cats were analysed as separate subgroups, the overall comparison was still significant. None of the individual pairwise comparisons reached statistical significance, though.
SAA did not appear to predict outcome. Seventeen cats survived to discharge. Admission levels did not differ significantly between survivors (median 12.2μg/mL) and non-survivors (27.4μg/mL). Of the five cats that died, four were in the inflammatory group: three arrested as their disease progressed, and one was euthanised. The fifth was a neoplastic case that was euthanised.
More work needed
No single biomarker, or combination of biomarkers, currently distinguishes reliably between the causes of respiratory signs in cats. The authors suggest SAA could help reduce reliance on more invasive diagnostics, and might eventually form part of a wider biomarker panel.
They stress that the study was small and retrospective. Larger, prospective studies are needed to validate the proposed cut-off. Further work is also needed to establish whether SAA can separate infectious from non-infectious inflammatory disease.



